GSK Can't Escape MDL Alleging Zofran Caused Birth Defects
A Massachusetts federal judge on Tuesday denied GlaxoSmithKline a quick win in multidistrict litigation claiming its anti-nausea drug Zofran led to birth defects, saying GSK has not proven the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article